Important safety informationRespiral is not a reliever medication. It must not be used to treat acute bronchospasm.
Respiratory

Respiral

respiflutide inhalation powder

Twice-daily maintenance therapy for persistent asthma.

Prescribing information revised 20 October 2026

About Respiral

Respiral (respiflutide) is an inhaled corticosteroid delivered by dry-powder inhaler, indicated for the maintenance treatment of asthma in patients aged 12 years and over.

Indications

  • Regular maintenance treatment of asthma in adults and adolescents aged 12 years and over.
  • Not indicated for the relief of acute bronchospasm.

For healthcare professionals